Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons E.A.M. Festen

Publicaties

Biologicals in the prevention and treatment of intestinal graft rejection: The state of the art Biologicals in Intestinal Transplantation

Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study

Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease

Genome-wide Studies Reveal Genetic Risk Factors for Hepatic Fat Content

Gut microbial metabolism of 5-aminosalicylic acid in inflammatory bowel disease

Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease

Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease

Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial

Health-related quality of life is linked to the gut microbiome in kidney transplant recipients

Health-Related Quality of Life is Linked to the Gut Microbiome in Kidney Transplant Recipients

Lees meer

Pers/media